- Diclofenac Sodium: Biofenac is indicated for the treatment of post operative inflammation in patient who have undergone cataract extraction and for the temporary relief of pain and photophobia in patiens undergoing corneal refractive surgery. It is also indicated in the treatment of conjunctivitis, keratoconjunctivitis, corneal ulcer and post traumatic inflammation of the cornea and conjunctiva, provided that these conditions are not associated with an ocular infection.
- Biofenac is also indicated to inhibit intraoperative miosis, which may occur in response to surgical trauma despite preoperative establishment of mydriasis.
Dosage and Administration:
- Cataract Surgery:
One drop of sodium diclofenac ophthalmic should be applied to the affected eye, 4 times daily beginning 24 hours after cataract surgery and continuing throughout the first 2 weeks of the medication.
- Corneal Refractive Surgery:
One or two drops of sodium ophthalmic should be applied to the operative eye within the hour prior to corneal refractive surgery. Within 15 minutes after surgery, one or two drops should be applied to the operative eye and continued 4times daily for up to 3 days.
Transient burning and stinging, keratitis, elevated intraocular peressure, lacrimation, abnormal vision, blurred vision, conjunctivitis, corneal deposits, corneal edema, corneal opacity, corneal lesions, discharge, eyelid swelling, iritis, irritation, itching.